Position in AMGN
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$143,278,245
+$1,127,187 QoQ
Shares Held
407,214
-6.2% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 65.57608530158589.ToString("F0")%
Shared 3.5413811902341275.ToString("F0")%
None 30.882533508179975.ToString("F0")%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026TRUIST FINANCIAL CORP holds $2,326,875,887 across 16 Drug Manufacturers - General names. AMGN ranks #7 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
2,404,493 | $522,953,181 | |
| 2 | JNJ |
Johnson & Johnson
|
2,044,092 | $499,657,847 | |
| 3 | LLY |
ELI LILLY & Co
|
369,521 | $339,874,329 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,221,085 | $267,174,314 | |
| 5 | AZN |
Astrazeneca PLC
|
754,121 | $148,727,743 | |
| 6 | NVS |
Novartis AG
|
941,818 | $143,862,698 | |
| 7 | AMGN |
Amgen Inc
This page
|
407,214 | $143,278,245 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,272,131 | $77,154,744 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $143,278,245 | 407,214 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $142,151,058 | 434,301 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $133,023,718 | 471,381 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $175,711,319 | 629,316 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $201,319,559 | 646,187 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $168,997,671 | 648,395 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $212,748,172 | 660,278 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $214,324,451 | 685,948 | Shares | Defined | 2024-08-21 | |
| 2024-03-31 | $180,302,379 | 634,153 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $193,244,713 | 670,942 | Shares | Defined | 2024-02-02 | |
| 2023-09-30 | $204,756,148 | 761,855 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $163,170,932 | 734,938 | Shares | Defined | 2023-08-01 | |
| 2023-03-31 | $199,132,616 | 823,713 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $214,728,947 | 817,579 | Shares | Defined | 2023-02-17 | |
| 2022-09-30 | $194,901,124 | 864,690 | Shares | Defined | 2022-10-26 | |
| 2022-06-30 | $205,875,105 | 846,178 | Shares | Defined | 2022-07-22 | |
| 2022-03-31 | $204,115,181 | 844,079 | Shares | Defined | 2022-04-22 | |
| 2021-12-31 | $180,548,321 | 802,544 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $172,885,511 | 813,005 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $196,433,736 | 805,882 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $202,385,287 | 813,413 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $191,000,749 | 830,727 | Shares | Defined | 2021-11-19 | |
| 2020-09-30 | $209,444,612 | 824,066 | Shares | Defined | 2021-11-05 | |
| 2020-06-30 | $205,128,147 | 869,703 | Shares | Defined | 2021-11-16 | |
| 2020-03-31 | $178,842,321 | 882,170 | Shares | Defined | 2021-11-05 | |
| No filing history on record for this holder in this stock. | ||||||